Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Ritchie

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nephron. Clinical Practice|January 18, 2014
Meta-analysis of lipid-lowering therapy in maintenance dialysis patientsDarren Green, James P Ritchie, Philip A Kalra
International Journal of Nephrology and Renovascular Disease|March 7, 2014
Revascularization as a treatment to improve renal functionHelen V Alderson, James P Ritchie, Philip A Kalra
Lancet (London, England)|August 28, 2015
Revascularisation of renal artery stenosis as a therapy for heart failure: an observational cohort studyDarren Green, James P Ritchie, Constantina Chrysochou, et al.
Nephrology (Carlton, Vic.)|February 28, 2017
Revascularization of atherosclerotic renal artery stenosis for chronic heart failure versus acute pulmonary oedemaDarren Green, James P Ritchie, Constantina Chrysochou, et al.
Journal of Renal Care|May 23, 2012
Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe?Darren Green, Rosica Panayotova, James P Ritchie, et al.
Nephron. Clinical Practice|May 3, 2013
How accurately do nephrologists predict the need for dialysis within one year?Darren Green, James P Ritchie, David I New, et al.
BMC Nephrology|June 3, 2014
Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trustRachael Challiner, James P Ritchie, Catherine Fullwood, et al.
Journal of Nephrology|February 13, 2014
The association of ECG and echocardiographic abnormalities with sudden cardiac death in a dialysis patient cohortDarren Green, James P Ritchie, Nik Abidin, et al.
Nephrology (Carlton, Vic.)|June 24, 2016
FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5Helen V Alderson, James P Ritchie, Rachel Middleton, et al.
The Journal of Chemical Physics|October 15, 2010
Thermally controlled preferential molecular aggregation state in a thiacarbocyanine dyeRémy Passier, James P Ritchie, Carlos Toro, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nephron. Clinical Practice|January 18, 2014
Meta-analysis of lipid-lowering therapy in maintenance dialysis patientsDarren Green, James P Ritchie, Philip A Kalra
International Journal of Nephrology and Renovascular Disease|March 7, 2014
Revascularization as a treatment to improve renal functionHelen V Alderson, James P Ritchie, Philip A Kalra
Lancet (London, England)|August 28, 2015
Revascularisation of renal artery stenosis as a therapy for heart failure: an observational cohort studyDarren Green, James P Ritchie, Constantina Chrysochou, et al.
Nephrology (Carlton, Vic.)|February 28, 2017
Revascularization of atherosclerotic renal artery stenosis for chronic heart failure versus acute pulmonary oedemaDarren Green, James P Ritchie, Constantina Chrysochou, et al.
Journal of Renal Care|May 23, 2012
Lipid-lowering therapy in chronic kidney disease: is there a role for ezetimibe?Darren Green, Rosica Panayotova, James P Ritchie, et al.
Nephron. Clinical Practice|May 3, 2013
How accurately do nephrologists predict the need for dialysis within one year?Darren Green, James P Ritchie, David I New, et al.
BMC Nephrology|June 3, 2014
Incidence and consequence of acute kidney injury in unselected emergency admissions to a large acute UK hospital trustRachael Challiner, James P Ritchie, Catherine Fullwood, et al.
Journal of Nephrology|February 13, 2014
The association of ECG and echocardiographic abnormalities with sudden cardiac death in a dialysis patient cohortDarren Green, James P Ritchie, Nik Abidin, et al.
Nephrology (Carlton, Vic.)|June 24, 2016
FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5Helen V Alderson, James P Ritchie, Rachel Middleton, et al.
The Journal of Chemical Physics|October 15, 2010
Thermally controlled preferential molecular aggregation state in a thiacarbocyanine dyeRémy Passier, James P Ritchie, Carlos Toro, et al.
Pageof 2